Ra Pharmaceuticals Inc

What indicators would you like to setup a trade for?

Candlestick Daily volume index Bar reversal Edit

Trade setup

Position Order Entry Exit Stop Loss Risk Return Expectancy
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%



Code Company Date Close Change Indicator Value Signal

Trading Performance

Rate of Change



Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 32 13.2 0.41% 0.68% 14.4% -5.1% 89.3%
SHORT 31 10.6 0.26% 0.33% 2.5% -5.7% -116.6%


Technical Analysis

Ra Pharmaceuticals Inc (RARX)



Last Signal:


Trading: SELL @ $46.9
Signal Strength: MEDIUM

Ra Pharmaceuticals Inc (NASDAQ:RARX) currently has negative rate of change of -0.064%. This means the current price is less than the price 14 days ago and therefore losing momentum.

Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. This indicator has the ability to detect the speed of movement & give an early signal for a potential movement. By understanding the rate at which the price is moving in respect to the stocks historical trades, enables positions to be set in place based on changes in the speed of movement

Rate of Change (ROC) is a refinement of Momentum - readings fluctuate as percentages around the zero line. The indicator is designed for use in ranging markets - to detect trend weakness and likely reversal points. However when combined with a trend indicator it can be used in trending markets.

Calculation: Rate of Change (ROC):
1) (Closing Price [today] - Closing Price [n days ago]) / Closing Price [n days ago] * 100

PROFILE: Ra Pharmaceuticals Inc (RARX)

Stock Exchange: NASDAQ
Company: Ra Pharmaceuticals Inc
Ticker Codes: | RARX | NASDAQ:RARX |

About Ra Pharmaceuticals Inc (NASDAQ:RARX):

Ra Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of diseases caused by excessive or uncontrolled activation of the complement system in the United States. The company's peptide chemistry platform enables the production of synthetic macrocyclic peptides that combine the diversity and specificity of antibodies with the pharmacological properties of small molecules. Its lead product candidate is RA101495, an injection into the tissue under the skin that has completed Phase II clinical trial for the treatment of paroxysmal nocturnal hemoglobinuria (PNH); and is in Phase II clinical trial for treating patients with generalized myasthenia gravis (gMG), as well as in Phase 1b clinical trial for treating atypical hemolytic uremic syndrome (aHUS) and lupus nephritis (LN). The company's preclinical testing products include Factor D inhibition for orphan renal and dense deposit diseases, and C3 glomerulonephritis; Oral C5 inhibitor for PNH, gMG, aHUS, LN, and central nervous system (CNS) diseases; and other complement inhibitors for autoimmune/CNS diseases. It has multi-target collaboration and license agreement with Merck & Co., Inc. Ra Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Cambridge, Massachusetts.

Top 10:

Rate of Change

Company Close Change(%) Volume Value Signal
IPHS Innophos 31.96 0 68,795 -0.06 BEARISH CROSSOVER
MPVD Mountain Province Diamonds 0.88 0 58,068 -0.87 BEARISH CROSSOVER
TNAV Telenav Inc 4.85 -0.2 109,696 -0.21 BEARISH CROSSOVER
PKOH Park Ohio 33.42 -0.4 17,990 -0.68 BEARISH CROSSOVER
OFIX Orthofix 45.89 -0.7 103,344 -0.63 BEARISH CROSSOVER
JOUT Johnson Outdoors 76.5 -0.8 38,890 -0.26 BEARISH CROSSOVER
TSCO Tractor Supply Co 92.91 -0.8 800,787 -0.57 BEARISH CROSSOVER
ASPS Altisource Portfolio 19.24 -1 55,325 -0.47 BEARISH CROSSOVER
KBAL Kimball Intl 20.49 -1 145,295 -0.87 BEARISH CROSSOVER
ORLY O'Reilly Automotive 435.71 -1.1 748,707 -0.58 BEARISH CROSSOVER